Discover Glo: Bioluminescent Cell-Based Assay Seminar Tour – London
Celebrating the launch of NanoLuc®, the most exciting new luciferase – and featuring presentations by leaders in the cellular analysis field, plus updates on the most recent products and technologies for cellular analysis from Promega.
Take the opportunity to network with fellow scientists and speakers during breaks and lunch in the historical surroundings of the Hotel Russell in London.
- The Hotel Russell in London. See map
- Date: Tuesday, March 5, 2013
- Time: 9:30 AM - 4:15 PM
Contact: hilary.latham@promega.com
Bioluminescent Cell-Based Assay Seminar Tour – London Event
The Agenda:
| 09.30 - 10.00 |
Arrival, register (entry into the prize draw) & coffee |
| 10.00 - 10.10 |
Welcome Address
Matt Cook (Head of Commercial Sales, Promega UK)
|
| 10.10 - 11.00 |
NanoLuc® Luciferase: A Smaller, Brighter & More Versatile Luciferase Reporter
Dr Terry Riss, Promega Corporation, Madison
Abstract and Biography »
|
| 11.00 - 11.45 |
Development of Cell-Based Assays to Investigate Modulators of SIRT1 Activity
Dr Vad Lazari, BioFocus
Abstract and Biography »
|
| 11.45 - 12.10 |
Coffee |
| 12.10 - 13.00 |
Generating Metabolically Active Hepatocytes From Pluripotent Stem Cells
Dr David Hay, Principal Investigator, MRC Centre for Regenerative Medicine, University of Edinburgh
Abstract and Biography »
|
| 13.00 - 14.00 |
Lunch |
| 14.00 - 14.45 |
A Novel Cell-Based Screening Approach for the Identification of FOXA1 Pathway Inhibitors for the Treatment of Tamoxifen-Resistant Breast Cancer
Dr Aurore Lejeune, Cancer Research Technology, London
Abstract »
|
| 14.45 - 15.10 |
The LIMD1 Protein Bridges an Association between the Prolyl Hydroxylases and VHL to Repress HIF1 Activity
Dr Daniel Foxler, Barts Cancer Centre
Abstract and Biography »
|
| 15.10 - 15.50 |
Cell-Based Assays to Detect the Mechanism of Toxicity
Dr Terry Riss, Promega Corporation, Madison
Abstract and Biography »
|
| 15.50 - 16.15 |
Wrap up, coffee and prize draw for iPad Mini |